Possible Anticancer Activity of Rosuvastatine, Doxazosin, Repaglinide and Oxcarbazepin

Cytotoxic evaluation of fluvastatin and rosuvastatin and effect of fluvastatin in the hela cell cycle

(2014) Mariacute;a Campos-Lara   African Journal of Pharmacy and Pharmacology

Statin Use and Reduced Cancer-Related Mortality

(2012) Sune F. Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer

(2011) Mark Stettner et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth

(2010) Nayana Ghosh-Choudhury et al.   CELLULAR SIGNALLING

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

(2010) Yin-Hsun Feng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Involvement of transcription factor activator protein-2α in doxazosin-induced HeLa cell apoptosis

(2008) Lu GAN et al.   ACTA PHARMACOLOGICA SINICA

Fluvastatin Inhibits Hepatitis C Replication in Humans

(2008) Ted Bader et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Glibenclamide exerts an antitumor activity through reactive oxygen species–c-jun NH(2)-terminal kinase pathway in human gastric cancer cell line MGC-803

(2008) Xia Qian et al.   BIOCHEMICAL PHARMACOLOGY

Neutral red uptake assay for the estimation of cell viability/cytotoxicity

(2008) Guillermo Repetto et al.   Nature Protocols

The α1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-κB signalling to induce breast cancer cell apoptosis

(2007) Hongxiang Hui et al.   EUROPEAN JOURNAL OF CANCER